Zona pellucida sperm-binding protein 3, Sperm receptor, ZP3A/ZP3B, Zona pellucida glycoprotein 3, Zp-3, Zona pellucida protein C, Processed zona pellucida sperm-binding protein 3, ZP3, ZP3A, ZP3B, ZPC
Product description
The zona pellucida is an extracellular matrix that
surrounds the oocyte and early embryo. It is composed primarily of
three or four glycoproteins with various functions during
fertilization and preimplantation development. The protein encoded
by this gene is a structural component of the zona pellucida and
functions in primary binding and induction of the sperm acrosome
reaction. The nascent protein contains a N-terminal signal peptide
sequence, a conserved ZP domain, a C-terminal consensus furin
cleavage site, and a transmembrane domain. It is hypothesized that
furin cleavage results in release of the mature protein from the
plasma membrane for subsequent incorporation into the zona
pellucida matrix. However, the requirement for furin cleavage in
this process remains controversial based on mouse studies. A
variation in the last exon of this gene has previously served as
the basis for an additional ZP3 locus; however, sequence and
literature review reveals that there is only one full-length ZP3
locus in the human genome. Another locus encoding a bipartite
transcript designated POMZP3 contains a duplication of the last
four exons of ZP3, including the above described variation, and
maps closely to this gene.1) Davila, S., et al. Genes Immun. 11(3):232-238(2010)
Immunogen
This ZP3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 353-380 amino acids from the C-terminal region of human ZP3.
Zona pellucida sperm-binding protein 3 Sperm receptor ZP3A/ZP3B Zona pellucida glycoprotein 3 Zp-3 Zona pellucida protein C Processed zona pellucida sperm-binding protein 3 ZP3 ZP3A ZP3B ZPC
Western blot analysis in human placenta tissue lysates (35ug/lane).
Application Notes
For WB starting dilution is: 1:1000:
Additional Information
Form
Liquid
Storage Instructions
Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.